Detection of PCR products using self-reporting duplex mutation primers

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Hepatitis B virus (HBV) infection is a significant global health concern.
• Accurate detection and quantification of HBV DNA are crucial for patient management and treatment monitoring.

Purpose of the Study:

• To design and evaluate a novel oligonucleotide probe for sensitive and specific detection of HBV DNA in serum.
• To compare the performance of the novel probe with a commercial TaqMan kit for HBV DNA quantification.

Main Methods:

• A novel oligonucleotide probe was designed, featuring a fluorophore-labeled normal reverse primer and a quencher-labeled mismatched complementary oligonucleotide.
• The probe's efficacy was assessed for HBV DNA detection in serum samples.
• Results were compared against a commercial TaqMan kit using samples from hepatitis B patients and healthy volunteers.

Main Results:

• The novel method demonstrated a good linear correlation (r(2) = 0.999) in the range of 10(2) to 10(7) copies/ml.
• Intra-experimental and inter-experimental coefficients of variation (CVs) were low, ranging from 0.70% to 9.02%.
• No significant difference was observed in HBV genome quantification between the novel method and the commercial kit (p<0.05).

Conclusions:

• The developed oligonucleotide probe offers a reliable and precise method for HBV DNA detection and quantification.
• This novel probe shows comparable performance to existing commercial kits, presenting a viable alternative for clinical diagnostics.
• The method effectively distinguished between infected patients and healthy individuals, confirming its diagnostic utility.